Skip to Content

Zhejiang Langhua Pharmaceutical, China, 2023

GMP Audit Report

Company
Zhejiang Langhua Pharmaceutical

Product(s)
Enrofloxacin

Country
China

Audit Year
2023

0.00 € 0.00 €
0.00 €